Fabio Cerignoli

An Automated Platform for Assessment of Congenital and Drug-Induced Arrhythmia with hiPSC-Derived Cardiomyocytes

Wesley L. McKeithan, Alex Savchenko, Michael S. Yu, 2017, Front. Physiol..

Human MRE11 is inactivated in mismatch repair‐deficient cancers

Alessandra Viel, Fabio Cerignoli, Marco Crescenzi, 2002, EMBO reports.

Multidentate small-molecule inhibitors of vaccinia H1-related (VHR) phosphatase decrease proliferation of cervix cancer cells.

Stefan Vasile, Maurizio Pellecchia, Fabio Cerignoli, 2009, Journal of medicinal chemistry.

Loss of the VHR dual-specific phosphatase causescell-cycle arrest and senescence

Fabio Cerignoli, Tomas Mustelin, Souad Rahmouni, 2006, Nature Cell Biology.

High throughput physiological screening of iPSC-derived cardiomyocytes for drug development.

Rolf Bodmer, Fabio Cerignoli, Derek Lemons, 2016, Biochimica et biophysica acta.

Luminescent silica nanobeads: characterization and evaluation as efficient cytoplasmatic transporters for T-lymphocytes.

Maurizio Pellecchia, Marilisa Leone, Fabio Cerignoli, 2007, Journal of the American Chemical Society.

High throughput measurement of Ca²⁺ dynamics for drug risk assessment in human stem cell-derived cardiomyocytes by kinetic image cytometry.

Fabio Cerignoli, Jeffrey H Price, Randy Ingermanson, 2012, Journal of pharmacological and toxicological methods.

Quantum dot-doped silica nanoparticles as probes for targeting of T-lymphocytes

Fabio Cerignoli, Tomas Mustelin, Andrea Magrini, 2007, International journal of nanomedicine.